CN103893625A - 一种治疗脑膜炎的混合中药 - Google Patents
一种治疗脑膜炎的混合中药 Download PDFInfo
- Publication number
- CN103893625A CN103893625A CN201410156995.0A CN201410156995A CN103893625A CN 103893625 A CN103893625 A CN 103893625A CN 201410156995 A CN201410156995 A CN 201410156995A CN 103893625 A CN103893625 A CN 103893625A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- grams
- traditional chinese
- meningitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 44
- 201000009906 Meningitis Diseases 0.000 title abstract description 22
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 241000628997 Flos Species 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 241000522254 Cassia Species 0.000 claims description 6
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 6
- 241000555712 Forsythia Species 0.000 claims description 6
- 241000245240 Lonicera Species 0.000 claims description 6
- 241001038563 Pseudostellaria Species 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 230000036461 convulsion Effects 0.000 abstract description 5
- 241000894006 Bacteria Species 0.000 abstract description 3
- 206010010904 Convulsion Diseases 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 230000035790 physiological processes and functions Effects 0.000 abstract description 3
- 230000006378 damage Effects 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 241000282817 Bovidae Species 0.000 abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000001256 tonic effect Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- 230000000840 anti-viral effect Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003443 antiviral agent Substances 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000001638 cerebellum Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002418 meninge Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- -1 phenethyl alcohol glycosides Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-Phenylethanol Natural products OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000006081 Cryptococcal meningitis Diseases 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010027202 Meningitis bacterial Diseases 0.000 description 1
- 206010027209 Meningitis cryptococcal Diseases 0.000 description 1
- 206010027241 Meningitis haemophilus Diseases 0.000 description 1
- 206010027259 Meningitis tuberculous Diseases 0.000 description 1
- 206010027260 Meningitis viral Diseases 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 208000022971 Tuberculous meningitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000009904 bacterial meningitis Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 208000001223 meningeal tuberculosis Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 201000010044 viral meningitis Diseases 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410156995.0A CN103893625B (zh) | 2014-04-18 | 2014-04-18 | 一种治疗脑膜炎的混合中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410156995.0A CN103893625B (zh) | 2014-04-18 | 2014-04-18 | 一种治疗脑膜炎的混合中药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103893625A true CN103893625A (zh) | 2014-07-02 |
CN103893625B CN103893625B (zh) | 2016-06-29 |
Family
ID=50985409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410156995.0A Active CN103893625B (zh) | 2014-04-18 | 2014-04-18 | 一种治疗脑膜炎的混合中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103893625B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189644A (zh) * | 2014-09-14 | 2014-12-10 | 洪满 | 治疗化脓性脑膜炎的组合中药 |
CN107233503A (zh) * | 2017-06-06 | 2017-10-10 | 郜宪林 | 一种缓解脑膜炎的中药组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101601830A (zh) * | 2009-07-10 | 2009-12-16 | 卢速江 | 一种治疗感冒的中药制剂及其制备方法 |
CN102205058A (zh) * | 2011-05-03 | 2011-10-05 | 曹建华 | 一种治疗惊厥型小儿流行性感冒的中药制备方法 |
CN103341038A (zh) * | 2013-07-22 | 2013-10-09 | 王兰美 | 一种治疗鸡新城疫、禽流行性感冒的中药配方 |
-
2014
- 2014-04-18 CN CN201410156995.0A patent/CN103893625B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101601830A (zh) * | 2009-07-10 | 2009-12-16 | 卢速江 | 一种治疗感冒的中药制剂及其制备方法 |
CN102205058A (zh) * | 2011-05-03 | 2011-10-05 | 曹建华 | 一种治疗惊厥型小儿流行性感冒的中药制备方法 |
CN103341038A (zh) * | 2013-07-22 | 2013-10-09 | 王兰美 | 一种治疗鸡新城疫、禽流行性感冒的中药配方 |
Non-Patent Citations (1)
Title |
---|
黎志远: "清瘟败毒饮治疗急重症3例", 《江西中医药》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104189644A (zh) * | 2014-09-14 | 2014-12-10 | 洪满 | 治疗化脓性脑膜炎的组合中药 |
CN107233503A (zh) * | 2017-06-06 | 2017-10-10 | 郜宪林 | 一种缓解脑膜炎的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN103893625B (zh) | 2016-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103768523A (zh) | 一种治疗恶性肿瘤中药复方制剂及其制备方法 | |
CN103610885B (zh) | 一种治疗皮疹的中药制剂 | |
CN102793848B (zh) | 一种治疗夜盲的中药散剂 | |
CN103893625B (zh) | 一种治疗脑膜炎的混合中药 | |
CN103520649B (zh) | 治疗面部神经炎的中药 | |
CN103623247A (zh) | 一种治疗眩晕症的药物 | |
CN101342331B (zh) | 治疗肺炎和上呼吸道感染的中药喷剂 | |
CN104189644A (zh) | 治疗化脓性脑膜炎的组合中药 | |
CN102793868B (zh) | 一种治疗喘促型闭合性骨折的中药洗剂制备方法 | |
CN104906268A (zh) | 治疗湿疹的中药外用剂及其制法 | |
CN104367827A (zh) | 一种治疗脾气虚弱证型多寐病的中药 | |
CN104147295A (zh) | 一种治腹泻的中药药剂 | |
CN103656599B (zh) | 一种治疗脾肾阳虚证型慢性结肠炎的中药 | |
CN103356779A (zh) | 一种预防及治疗抽筋的药酒 | |
CN102846998A (zh) | 一种治疗慢性肠炎(脾虚泻利)的中药方 | |
CN105663483A (zh) | 一种治疗虫积型缺铁性贫血的中药组合物及其制备方法 | |
CN104367910A (zh) | 一种治疗湿盛困脾型多寐病的中药 | |
CN105456999A (zh) | 用于治疗发烧的药物 | |
CN105168947A (zh) | 一种治疗肝阴不足证型胁痛的中药组合物 | |
CN104906352A (zh) | 一种治疗虚火上炎型小儿口疮的中药药液及其制备方法 | |
CN105079141A (zh) | 一种治疗牦牛肺炎的藏兽药组合物及其制备方法和应用 | |
CN104689202A (zh) | 治疗蛔虫病的中药 | |
CN104644868A (zh) | 一种治疗由风湿热引起的关节炎的中药组合物及其制法 | |
CN105288174A (zh) | 一种治疗溃疡性结肠炎中药 | |
CN104161827A (zh) | 治疗鸡霍乱的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 536000 the Guangxi Zhuang Autonomous Region Beihai city Chongqing road at Garden Building 2 unit A 402 mailbox Applicant after: Zhang Wenyan Address before: 535000, C2BB402, two, Bailey, Qinzhou, the Guangxi Zhuang Autonomous Region Applicant before: Zhang Wenyan |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 535400 Qinzhou County, Lingshan City, the Guangxi Zhuang Autonomous Region, six Peak Road, Lingshan county science and technology information Patentee after: Zhang Wenyan Address before: 536000 the Guangxi Zhuang Autonomous Region Beihai city Chongqing road at Garden Building 2 unit A 402 mailbox Patentee before: Zhang Wenyan |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190226 Address after: 233010 409 Wu Wan Road, Yuhui District, Bengbu, Anhui Patentee after: BENGBU JINSHI NEW MATERIAL Co.,Ltd. Address before: 230031 B-1014, 10 floor, business office building, Wo Ye garden, Shushan District, Hefei, Anhui. Patentee before: HEFEI WISDOM LOTUT INTELLECTUAL PROPERTY Co.,Ltd. Effective date of registration: 20190226 Address after: 230031 B-1014, 10 floor, business office building, Wo Ye garden, Shushan District, Hefei, Anhui. Patentee after: HEFEI WISDOM LOTUT INTELLECTUAL PROPERTY Co.,Ltd. Address before: 535400 Lingshan Science and Technology Information Institute, Liufeng Road, Lingshan County, Lingshan County, Qinzhou City, Guangxi Zhuang Autonomous Region Patentee before: Zhang Wenyan |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190711 Address after: 230000 B-1512, west of Ganquan Road, Shushan District, Hefei, Anhui. Patentee after: ANHUI YINGLONG INDUSTRIAL DESIGN Co.,Ltd. Address before: 233010 409 Wu Wan Road, Yuhui District, Bengbu, Anhui Patentee before: BENGBU JINSHI NEW MATERIAL Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191114 Address after: 363200, Zhangzhou, Fujian province Zhangpu Sui An Industrial Zone Patentee after: TONGYITANG PHARMACEUTICAL Co.,Ltd. Address before: Ganquan road Shushan District of Hefei City, Anhui Province, 230000 West hillock road to the South Wild Garden commercial office building room B-1512 Patentee before: ANHUI YINGLONG INDUSTRIAL DESIGN Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A mixed traditional Chinese medicine for treating meningitis Effective date of registration: 20231231 Granted publication date: 20160629 Pledgee: Bank of China Limited by Share Ltd. Zhangpu branch Pledgor: TONGYITANG PHARMACEUTICAL Co.,Ltd. Registration number: Y2023980075812 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |